NMC Health

  • TickerNMC
  • ISINGB00B7FC0762
  • ExchangeLondon Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited Kingdom

Analysts

NMC HEALTH PLC. sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of NMC HEALTH PLC. (GB), active in the Health Care Providers industry. As regards its fundamental valuation, the title now shows 2 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date October 4, 2019, the closing price was GBp 2,501.00 and its target price was estimated at GBp 1,962.80.

Expert Corporate Governance Service (ECGS)

NMC Health 20 June 2019

Item 2: Approve the Remuneration ReportThe structure is considered acceptable. However, the STI and the LTI are overly reliant on a sole performance metric, EBITDA. Furthermore, pay is only slightly weighted toward the long-term. Actual incentive pay for the year exceeded ECGS guidelines, though concern with this is partially mitigated by the lower base salary. Nevertheless, on balance, we recommend shareolders oppose. Items 6-16: Re-elect the Board of DirectorsThere is insufficient independent representation on the Board and insufficient gender diversity. One of the joint Chairman is the for...

1 director bought

A director at NMC Health bought 75,000 shares at 2,495p and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board memb...

Jérôme VINERIER

Short term view - NMC HEALTH PLC : The trend is bearish.

The trend is bearish. The bounce is gaining strength. The bounce might end at the resistance at 3,532.50 p and prices would fall again toward 2,964.00 p. The background trend would be questioned should prices rise above 3,719.30 p.

Jérôme VINERIER

Analyse court terme - NMC HEALTH PLC : La tendance est baissière.

La tendance est baissière. Le rebond gagne en vigueur. Il est probable que cette reprise s'achève sur la résistance à 3 532,50 p et que les prix baissent à nouveau vers 2 964,00 p. La tendance de fond serait remise en cause en cas de franchissement de 3 719,30 p.

Khaled Sadek

On an M&A spree; Reiterate Overweight

Consolidation story continues to unfold. We raise our TP by 19% to GBP41.5/share, incorporating NMC’s 1H18 acquisitions in our numbers, including the company’s remaining minority stakes in Fakih IVF (49%) in the UAE and As Salama Hospital (30%) in the KSA, as well as the acquisitions of Al Salam Medical Group (80%) in KSA, CosmeSurge (70%) in the UAE, and as we roll over our DCF. NMC’s superior growth profile (2018-22 EPS CAGR 31% vs. peers’ 18%) warrants a premium to peers, in our view. Nonetheless, the stock trades on a 2018e EV/EBITDA of 20.6x(vs. c17x for Saudi peers), at a 30% growth adju...

Khaled Sadek

Regional outreach parallels local growth; initiate with Overweight

Accretive acquisitions complement organic growth. NMC is set to increase its operational bed capacity by 2.9x over 2016-19, adding 1,279 beds across the multispecialty and long-term care verticals, split as 690 beds in Saudi, 487 beds in UAE (mainly Abu Dhabi and Sharjah) and 102 beds in Oman. We estimate these additions to expand 2017e EBITDA margin by 266bps to 24.5% by 2022 (in line with guidance). The main driver is organic growth and margin expansion, while NMC’s recent foray into Saudi multispecialty hospitals should contribute c9% to 2022 revenue. We believe that the stock still has roo...

1 director bought

A director at NMC Health bought 75,000 shares at 2,495p and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board memb...

NMC HEALTH PLC. sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of NMC HEALTH PLC. (GB), active in the Health Care Providers industry. As regards its fundamental valuation, the title now shows 2 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date October 4, 2019, the closing price was GBp 2,501.00 and its target price was estimated at GBp 1,962.80.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Expert Corporate Governance Service (ECGS)

NMC Health 20 June 2019

Item 2: Approve the Remuneration ReportThe structure is considered acceptable. However, the STI and the LTI are overly reliant on a sole performance metric, EBITDA. Furthermore, pay is only slightly weighted toward the long-term. Actual incentive pay for the year exceeded ECGS guidelines, though concern with this is partially mitigated by the lower base salary. Nevertheless, on balance, we recommend shareolders oppose. Items 6-16: Re-elect the Board of DirectorsThere is insufficient independent representation on the Board and insufficient gender diversity. One of the joint Chairman is the for...

Jérôme VINERIER

Short term view - NMC HEALTH PLC : The trend is bearish.

The trend is bearish. The bounce is gaining strength. The bounce might end at the resistance at 3,532.50 p and prices would fall again toward 2,964.00 p. The background trend would be questioned should prices rise above 3,719.30 p.

Jérôme VINERIER

Analyse court terme - NMC HEALTH PLC : La tendance est baissière.

La tendance est baissière. Le rebond gagne en vigueur. Il est probable que cette reprise s'achève sur la résistance à 3 532,50 p et que les prix baissent à nouveau vers 2 964,00 p. La tendance de fond serait remise en cause en cas de franchissement de 3 719,30 p.

Jérôme VINERIER

Analyse court terme - NMC HEALTH PLC : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Le MACD est négatif, il confirme cette tendance. La reprise est une consolidation qui va buter sur 3 532,50 p prochainement. Le prochain objectif est à 2 964,00 p, puis 2 651,50 p. Le franchissement de 3 719,30 p remettrait en cause la suite de la baisse.

Jérôme VINERIER

Short term view - NMC HEALTH PLC : The background trend is clearly bearish.

The background trend is clearly bearish. The negative MACD confirms the trend. The rise is a consolidation that will soon bump against the level at 3,532.50 p. The next target is at 2,964.00 p, then 2,651.50 p. Passing 3,719.30 p would question the continuation of the fall.

Jérôme VINERIER

Medium term view - NMC HEALTH PLC : The trend is bullish.

The trend is bullish. The recent fall is getting more vigorous. The next support is at 3,000.00 p. A break below 3,000.00 p would challenge the trend.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch